JP2023524130A5 - - Google Patents
Info
- Publication number
- JP2023524130A5 JP2023524130A5 JP2022567280A JP2022567280A JP2023524130A5 JP 2023524130 A5 JP2023524130 A5 JP 2023524130A5 JP 2022567280 A JP2022567280 A JP 2022567280A JP 2022567280 A JP2022567280 A JP 2022567280A JP 2023524130 A5 JP2023524130 A5 JP 2023524130A5
- Authority
- JP
- Japan
- Prior art keywords
- complement
- peptides
- subject
- protein
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2006789.8 | 2020-05-07 | ||
| GBGB2006789.8A GB202006789D0 (en) | 2020-05-07 | 2020-05-07 | Detection of complement proteins |
| PCT/EP2021/062077 WO2021224430A1 (en) | 2020-05-07 | 2021-05-06 | Detection of complement proteins |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023524130A JP2023524130A (ja) | 2023-06-08 |
| JP2023524130A5 true JP2023524130A5 (enExample) | 2024-05-17 |
| JP7849304B2 JP7849304B2 (ja) | 2026-04-21 |
Family
ID=71134867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022567280A Active JP7849304B2 (ja) | 2020-05-07 | 2021-05-06 | 補体タンパク質の検出 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230400470A1 (enExample) |
| EP (1) | EP4147057A1 (enExample) |
| JP (1) | JP7849304B2 (enExample) |
| CN (1) | CN115997127A (enExample) |
| AU (1) | AU2021267650A1 (enExample) |
| CA (1) | CA3177760A1 (enExample) |
| GB (1) | GB202006789D0 (enExample) |
| WO (1) | WO2021224430A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
| GB202203627D0 (en) * | 2022-03-16 | 2022-04-27 | Univ Manchester | Agents for treating complement-related disorders |
| JP2026501750A (ja) | 2023-01-05 | 2026-01-16 | コンプリメント・セラピューティクス・リミテッド | 補体疾患を処置するための薬剤および方法 |
| WO2025083211A1 (en) * | 2023-10-20 | 2025-04-24 | Institut National de la Santé et de la Recherche Médicale | Use of factor h for the treatment of dementia |
| LU103244B1 (en) | 2024-02-14 | 2025-08-14 | Univ Hamburg Eppendorf Uke | Deletion of the mouse homolog of human FHR1 (FHRE) protects ApoE-/- mice from atherosclerosis |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005211063A (ja) | 2004-01-30 | 2005-08-11 | Junko Maekuroshima | ブレンドノニ茶 |
| WO2008005455A2 (en) | 2006-07-03 | 2008-01-10 | The Johns Hopkins University | Peptide antibody depletion and its application to mass spectrometry sample preparation |
| WO2009059321A2 (en) | 2007-11-01 | 2009-05-07 | University Of Iowa Research Foundation | Rca locus analysis to assess susceptibility to amd and mpgnii |
| GB0815576D0 (en) | 2008-08-28 | 2008-10-01 | Lucas & Co | Analysis of glycated proteins |
| WO2016068616A1 (ko) | 2014-10-29 | 2016-05-06 | 차의과학대학교 산학협력단 | C3 또는 c1r 보체를 분비하는 태반 유래 세포 및 이를 포함하는 조성물 |
| GB201709222D0 (en) | 2017-06-09 | 2017-07-26 | Univ Manchester | C3b Inactivating Polypeptide |
| GB201800620D0 (en) | 2018-01-15 | 2018-02-28 | Univ Manchester | C3b Binding Polypeptide |
| KR102775717B1 (ko) | 2018-03-13 | 2025-03-06 | 암젠 인크 | 질량 분광 분석을 위한 폴리펩티드의 순차적 소화 |
| WO2019215330A1 (en) | 2018-05-10 | 2019-11-14 | The University Of Manchester | Methods for assessing macular degeneration |
-
2020
- 2020-05-07 GB GBGB2006789.8A patent/GB202006789D0/en not_active Ceased
-
2021
- 2021-05-06 WO PCT/EP2021/062077 patent/WO2021224430A1/en not_active Ceased
- 2021-05-06 CN CN202180033713.6A patent/CN115997127A/zh active Pending
- 2021-05-06 CA CA3177760A patent/CA3177760A1/en active Pending
- 2021-05-06 AU AU2021267650A patent/AU2021267650A1/en active Pending
- 2021-05-06 JP JP2022567280A patent/JP7849304B2/ja active Active
- 2021-05-06 EP EP21725088.5A patent/EP4147057A1/en active Pending
-
2022
- 2022-11-04 US US18/052,795 patent/US20230400470A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023524130A5 (enExample) | ||
| Jian et al. | Association between progranulin and Gaucher disease | |
| Ahuja et al. | Serum vascular endothelial growth factor is a biomolecular biomarker of severity of diabetic retinopathy | |
| Zhang et al. | Dynamic changes of CX3CL1/CX3CR1 axis during microglial activation and motor neuron loss in the spinal cord of ALS mouse model | |
| Leyhe et al. | Modulation of β-amyloid by a single dose of GSK933776 in patients with mild Alzheimer’s disease: a phase I study | |
| Toledo et al. | Plasma amyloid beta measurements-a desired but elusive Alzheimer's disease biomarker | |
| Bertram et al. | TREM2 and neurodegenerative disease | |
| US10888600B2 (en) | Methods and agents for treating Alzheimer's disease | |
| JP7260248B2 (ja) | 細胞透過性抗体 | |
| Gos et al. | Contribution of RIT1 mutations to the pathogenesis of Noonan syndrome: four new cases and further evidence of heterogeneity | |
| JP2022519583A5 (enExample) | ||
| JP2017533889A5 (enExample) | ||
| Dunmore et al. | 4PBA restores signaling of a cysteine-substituted mutant BMPR2 receptor found in patients with pulmonary arterial hypertension | |
| JP7849304B2 (ja) | 補体タンパク質の検出 | |
| JP2007521015A5 (enExample) | ||
| Chen et al. | Clinical and molecular characterization of non-syndromic retinal dystrophy due to c. 175G> A mutation in ceroid lipofuscinosis neuronal 3 (CLN3) | |
| JP2022513721A5 (enExample) | ||
| Katagiri et al. | Compound heterozygous splice site variants in the SCLT1 gene highlight an additional candidate locus for Senior-Løken syndrome | |
| JP2023543763A5 (enExample) | ||
| Wan et al. | Long non-coding RNA H19 deficiency ameliorates bleomycin-induced pulmonary inflammation and fibrosis | |
| Caron et al. | Elevated plasma and CSF neurofilament light chain concentrations are stabilized in response to mutant huntingtin lowering in the brains of Huntington’s disease mice | |
| JP4820092B2 (ja) | 転移のための新規な因子及びその使用 | |
| Wang et al. | Novel mutations of the ALMS1 Gene in patients with Alström syndrome | |
| Mankoč Ramuš et al. | The GG genotype of erythropoietin rs1617640 polymorphism affects the risk of proliferative diabetic retinopathy in Slovenian subjects with type 2 diabetes mellitus: enemy or ally? | |
| Li et al. | DENND3 p. L708V activating variant is involved in the pathogenesis of hereditary hemochromatosis via the RAB12/TFR2 signaling pathway |